Zepp Health ADR A ADR Stock
Zepp Health ADR A ADR Stock price
Key metrics
| Market capitalization | $19.08m |
| Enterprise Value | $99.95m |
| P/E (TTM) P/E ratio | negative |
| EV/Sales (TTM) EV/Sales | 0.55 |
| P/S ratio (TTM) P/S ratio | 0.11 |
| P/B ratio (TTM) P/B ratio | 0.08 |
| Revenue growth (TTM) Revenue growth | -39.27% |
| Revenue (TTM) Revenue | $181.18m |
| EBIT (operating result TTM) EBIT | $-49.72m |
Is Zepp Health ADR A ADR a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 6,789 stocks worldwide.
Zepp Health ADR A ADR Stock Analysis
Analyst Opinions
1 Analyst has issued a forecast Zepp Health ADR A ADR:
Analyst Opinions
1 Analyst has issued a forecast Zepp Health ADR A ADR:
Financial data from Zepp Health ADR A ADR
| Mar '25 |
+/-
%
|
||
| Revenue | 181 181 |
39%
39%
|
|
| Gross Profit | 70 70 |
23%
23%
|
|
| EBITDA | - - |
-
|
EBIT (Operating Income) EBIT | -50 -50 |
108%
108%
|
| Net Profit | -81 -81 |
218%
218%
|
|
In millions USD.
Don't miss a Thing! We will send you all news about Zepp Health ADR A ADR directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Zepp Health ADR A ADR Stock News
Company Profile
Zepp Health Corp. engages in the development, manufacture, and sale of smart wearable technology devices. It operates through Xiaomi Wearable Products, and Self-branded Products and Others segments. The Xiaomi Wearable Products segment comprises of sales of Xiaomi-branded products. The Self-branded Products and Others segment includes self-branded products. The company was founded by Huang Wang in December 2014 and is headquartered in Hefei, China.
| Head office | Cayman Islands |
| CEO | Wang Huang |
| Employees | 765 |
| Founded | 2013 |
| Website | www.zepp.com |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
